Contribution of prenatal endocrine-disrupting chemical exposure to genital anomalies in males: The pooled results from current evidence

Chemosphere. 2022 Jan;286(Pt 3):131844. doi: 10.1016/j.chemosphere.2021.131844. Epub 2021 Aug 9.

Abstract

The etiology of hypospadias and cryptorchidism, which are the two most common genital anomalies in males, has not been elucidated. Although prenatal exposure to endocrine-disrupting chemicals (EDCs) may increase the risks of hypospadias and cryptorchidism, the associations have not been confirmed. Therefore, we performed a meta-analysis to establish the relationships between prenatal exposure to EDCs and male genital anomalies. A systematic search of PubMed, EMbase, and Cochrane Library CENTRAL for relevant published studies providing quantitative data on the associations between prenatal EDCs exposure and hypospadias/cryptorchidism in humans was conducted. In total, sixteen case-controlled studies were included. Prenatal exposure to overall EDCs was associated with an increased risk of hypospadias in males (OR, 1.34, 95 % CI 1.12 to 1.60). Although there was no statistically significant association between overall EDCs exposure and cryptorchidism (OR, 1.11, 95 % CI 0.99 to 1.24), exposure to phenol substances was associated with an increased risk of cryptorchidism (OR, 1.81, 95 % CI, 1.12 to 2.93). Using the GRADE tool, we found the overall evidence to be of moderate certainty. In conclusion, the current evidence suggests prenatal EDCs exposure may increase the risk of hypospadias in males.

Keywords: Cryptorchidism; Endocrine-disrupting chemicals; Hypospadias; Prenatal exposure.

Publication types

  • Meta-Analysis

MeSH terms

  • Case-Control Studies
  • Cryptorchidism* / chemically induced
  • Cryptorchidism* / epidemiology
  • Endocrine Disruptors* / toxicity
  • Female
  • Genitalia
  • Humans
  • Hypospadias* / chemically induced
  • Hypospadias* / epidemiology
  • Male
  • Pregnancy

Substances

  • Endocrine Disruptors